Alphatec Holdings (NASDAQ: ATEC) and Sequenom (NASDAQ:SQNM) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.

Profitability

This table compares Alphatec Holdings and Sequenom’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Alphatec Holdings -25.13% N/A -31.74%
Sequenom -21.54% N/A -25.05%

Institutional & Insider Ownership

20.6% of Alphatec Holdings shares are held by institutional investors. Comparatively, 46.0% of Sequenom shares are held by institutional investors. 23.6% of Alphatec Holdings shares are held by insiders. Comparatively, 3.1% of Sequenom shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Alphatec Holdings and Sequenom’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Alphatec Holdings $106.16 million N/A -$2.79 million ($3.01) -0.70
Sequenom N/A N/A N/A ($0.34) -7.03

Sequenom has higher revenue, but lower earnings than Alphatec Holdings. Sequenom is trading at a lower price-to-earnings ratio than Alphatec Holdings, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Alphatec Holdings has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500. Comparatively, Sequenom has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Alphatec Holdings and Sequenom, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec Holdings 0 0 1 0 3.00
Sequenom 0 0 0 0 N/A

Alphatec Holdings currently has a consensus price target of $4.00, indicating a potential upside of 90.48%. Given Alphatec Holdings’ higher possible upside, equities research analysts plainly believe Alphatec Holdings is more favorable than Sequenom.

Summary

Alphatec Holdings beats Sequenom on 5 of the 9 factors compared between the two stocks.

Alphatec Holdings Company Profile

Alphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its products include Cervical and Cervico-Thoracic Products, which include Trestle Luxe Anterior Cervical Plate System and Pegasus Anchored Cervical Interbody; Thoracolumbar Fixation Products, which include Arsenal Degenerative System and OsseoScrew Spinal Fixation System; Spinal Spacers, which include Battalion Universal Spacer System and Alphatec Solus Locking ALIF Spinal Spacer; minimally invasive surgery Products, which include Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System, and Biologics, which include Neocore Osteoconductive Matrix.

Sequenom Company Profile

Sequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company’s diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories’ test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.

Receive News & Stock Ratings for Alphatec Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec Holdings Inc. and related stocks with our FREE daily email newsletter.